A Study of Anlotinib in Subjects With Advanced Malignancy

Clinical trial NCT04216082 · COMPLETED

Trial details

NCT number: NCT04216082
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignancy

Start date: 2013-08-01
Primary completion: 2014-08-31
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.